Skip to main content
See every side of every news story
Published loading...Updated

Mounjaro Found Safe, Effective in Kids With Type 2 Diabetes

Summary by MedPage Today
(MedPage Today) -- Tirzepatide (Mounjaro) improved glucose control and body mass index (BMI) in children with type 2 diabetes who were inadequately controlled with metformin and basal insulin, the phase III SURPASS-PEDS trial showed. Among 99...

3 Articles

Mounjaro, an injectable pen for type 2 diabetes and obesity, was shown to be effective and safe for children and adolescents between 10 and 18 years of age in a new study published on this Thursday (18). The results of the work were presented at the European Association for Diabetes Study (EASD) Annual Meeting and published in The Lancet scientific magazine. The study SURPASS-PEDS was the first to evaluate the safety and efficacy of trizepatitis…

·Brazil
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

CNN Brasil broke the news in Brazil on Thursday, September 18, 2025.
Sources are mostly out of (0)

Similar News Topics

News
For You
Search
BlindspotLocal